ABUS vs HCAT
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
ABUS
HCAT
Investment Advisor Scores
HCAT
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ABUS | HCAT | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.2459 | 10 | HCAT |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -43.5% | -26.3% | HCAT |
| Earnings Growth | 0.0% | 0.0% | Tie |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.5/100 | 51.6/100 | ABUS |
| Profit Margin | 121.2% | -74.2% | ABUS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ABUS
MarkdownPrice below a falling SMA50 (slope -6.5%), weak momentum, RSI 40
HCAT
MarkdownPrice below a falling SMA50 (slope -2.6%), weak momentum, RSI 37
Fundamentals Snapshot
| Metric | ABUS | HCAT |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -35.0 | -572.0 |
| Trailing P/E | 3.4 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.4% | -0.3% |
| Gross Margin | 0.9% | 0.5% |
| Operating Margin | -34.4% | -0.2% |
| EPS | 1.12 | -2.80 |
| Dividend Yield | — | — |